共 69 条
[1]
Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C., Functional bowel disorders, Gastroenterology, 130, pp. 1480-1491, (2006)
[2]
Drossman D.A., Chang L., Bellamy N., Gallo-Torres H.E., Lembo A., Mearin F., Norton N.J., Whorwell P., Severity in irritable bowel syndrome: A rome foundation working team report, Am J Gastroenterol., 106, pp. 1749-1759, (2011)
[3]
Lovell R.M., Ford A.C., Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis, Clin Gastroenterol Hepatol, (2012)
[4]
Drossman D.A., Creed F.H., Olden K.W., Svedlund J., Toner B.B., Whitehead W.E., Psychosocial aspects of the functional gastrointestinal disorders, Gut, 45, SUPPL. 2, (1999)
[5]
Gunnarsson J., Simren M., Peripheral factors in the pathophysiology of irritable bowel syndrome, Dig Liver Dis, 41, pp. 788-793, (2009)
[6]
Akehurst R., Kaltenthaler E., Treatment of irritable bowel syndrome: A review of randomised controlled trials, Gut, 48, 2, pp. 272-282, (2001)
[7]
Kearney D.J., Brown-Chang J., Complementary and alternative medicine for IBS in adults: Mind-body interventions, Nat Clin Pract Gastroenterol Hepatol., 5, pp. 624-636, (2008)
[8]
Koloski N.A., Talley N.J., Huskic S.S., Boyce P.M., Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia, Alimentary Pharmacology and Therapeutics, 17, 6, pp. 841-851, (2003)
[9]
Kong S.C., Hurlstone D.P., Pocock C.Y., Walkington L.A., Farquharson N.R., Bramble M.G., McAlindon M.E., Sanders D.S., The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases, Journal of Clinical Gastroenterology, 39, 2, pp. 138-141, (2005)
[10]
Van Tilburg M.A., Palsson O.S., Levy R.L., Feld A.D., Turner M.J., Drossman D.A., Whitehead W.E., Complementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a large HMO, BMC Complement Altern Med., 8, (2008)